News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,403 Results
Type
Article (49659)
Company Profile (278)
Press Release (683466)
Section
Business (212254)
Career Advice (2098)
Deals (36531)
Drug Delivery (103)
Drug Development (83595)
Employer Resources (173)
FDA (16953)
Job Trends (15705)
News (359171)
Policy (34658)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2774)
Accelerated approval (2)
Adcomms (23)
Allergies (83)
Alliances (51541)
ALS (85)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (112)
Approvals (16951)
Artificial intelligence (247)
Autoimmune disease (14)
Automation (14)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (191)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (257)
Cancer (2013)
Cardiovascular disease (157)
Career advice (1758)
Career pathing (30)
CAR-T (142)
Cell therapy (398)
Cervical cancer (19)
Clinical research (67574)
Collaboration (783)
Compensation (449)
Complete response letters (20)
COVID-19 (2708)
CRISPR (35)
C-suite (212)
Cystic fibrosis (99)
Data (1919)
Decentralized trials (2)
Denatured (26)
Depression (43)
Diabetes (248)
Diagnostics (6540)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (110)
Drug pricing (102)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (88263)
Editorial (34)
Employer branding (21)
Employer resources (147)
Events (116581)
Executive appointments (642)
FDA (18081)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (702)
Gene editing (98)
Generative AI (24)
Gene therapy (277)
GLP-1 (729)
Government (4648)
Grass and pollen (4)
Guidances (48)
Healthcare (19890)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (105)
Indications (27)
Infectious disease (2842)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (83)
Interviews (319)
IPO (16852)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (34)
Layoffs (466)
Leadership (16)
Legal (8454)
Liver cancer (73)
Lung cancer (296)
Lymphoma (130)
Machine learning (2)
Management (58)
Manufacturing (270)
MASH (62)
Medical device (14317)
Medtech (14322)
Mergers & acquisitions (20148)
Metabolic disorders (655)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (86)
Neuropsychiatric disorders (28)
Neuroscience (1889)
NextGen: Class of 2025 (6910)
Non-profit (4736)
Northern California (2403)
Now hiring (37)
Obesity (359)
Opinion (215)
Ovarian cancer (72)
Pain (80)
Pancreatic cancer (77)
Parkinson's disease (135)
Partnered (18)
Patents (202)
Patient recruitment (95)
Peanut (48)
People (59902)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21019)
Phase II (29691)
Phase III (22192)
Pipeline (969)
Podcasts (57)
Policy (110)
Postmarket research (2741)
Preclinical (8934)
Press Release (67)
Prostate cancer (94)
Psychedelics (32)
Radiopharmaceuticals (253)
Rare diseases (361)
Real estate (6297)
Recruiting (65)
Regulatory (23536)
Reports (46)
Research institute (2478)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (68)
Series A (121)
Series B (79)
Service/supplier (13)
Sickle cell disease (50)
Southern California (2082)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (13)
Supply chain (62)
The Weekly (28)
United States (21331)
Vaccines (691)
Venture capitalists (38)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (15)
Date
Today (27)
Last 7 days (575)
Last 30 days (2675)
Last 365 days (34336)
2025 (7839)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (793)
Alabama (50)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40852)
Australia (6733)
California (5499)
Canada (1866)
China (482)
Colorado (255)
Connecticut (272)
Delaware (126)
Europe (88426)
Florida (816)
Georgia (198)
Idaho (61)
Illinois (528)
India (23)
Indiana (295)
Iowa (9)
Japan (139)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (863)
Massachusetts (4180)
Michigan (214)
Minnesota (381)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (67)
New Jersey (1577)
New Mexico (29)
New York (1581)
North Carolina (974)
North Dakota (7)
Northern California (2403)
Ohio (192)
Oklahoma (14)
Oregon (34)
Pennsylvania (1246)
Puerto Rico (9)
Rhode Island (28)
South America (1183)
South Carolina (19)
South Dakota (1)
Southern California (2082)
Tennessee (94)
Texas (824)
Utah (167)
Virginia (132)
Washington D.C. (61)
Washington State (523)
West Virginia (3)
Wisconsin (49)
733,403 Results for "miromatrix medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
United Therapeutics to Acquire Miromatrix Medical
United Therapeutics Corporation and Miromatrix Medical Inc. announced a definitive agreement for United Therapeutics to acquire Miromatrix.
October 30, 2023
·
9 min read
Deals
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
United Therapeutics Corporation and Miromatrix Medical Inc. announced the results of the previously announced tender offer by Morpheus Subsidiary Inc., a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix.
December 12, 2023
·
5 min read
Deals
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger.
December 13, 2023
·
4 min read
Business
Miromatrix Reports Third Quarter 2023 Results
Miromatrix Medical Inc. (Nasdaq: MIRO) (the “Company”), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported third quarter 2023 financial results.
November 14, 2023
·
10 min read
Deals
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
Miromatrix Medical Inc. today announced that it has commenced an underwritten public offering of shares of its common stock.
March 7, 2023
·
5 min read
BioMidwest
Miromatrix to Present at the 2023 ISODP Organ Donation Congress
Miromatrix Medical Inc. (NASDAQ: MIRO) today announced that it will be presenting at the 2023 International Society for Organ Donation and Procurement (“ISODP”) Organ Donation Congress in Las Vegas, NV on October 18-21 at Mandalay Bay Resort.
October 11, 2023
·
1 min read
BioMidwest
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop
Miromatrix Medical Inc. announced its participation in the upcoming Alliance for Regenerative Medicine Tissue Engineering and Therapeutics Workshop held on September 6, 2023.
September 5, 2023
·
1 min read
BioMidwest
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock at a price to the public of $1.60 per share, before underwriting discounts and commissions.
March 7, 2023
·
5 min read
BioMidwest
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
Miromatrix Medical Inc., a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that CEO Jeff Ross will present at the 2023 Cell & Gene Meeting on the Mesa in Carlsbad, CA.
October 5, 2023
·
1 min read
BioMidwest
Miromatrix Presenting at the 2023 American Transplant Congress
Miromatrix Medical Inc. announced it will be presenting at the upcoming 2023 American Transplant Congress held on June 3rd to June 7th, 2023 in San Diego, California.
May 30, 2023
·
1 min read
1 of 73,341
Next
